Patent US4952501A successfully refreshed from Google Patents.
US4952501A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for analyzing and synthesizing functional polypeptide sequences for assembly into enhanced or multi-functional proteins
Assignee: Massachusetts Institute of Technology
•
Filing: 1988-04-26
•
Granted: 1990-08-28
•
Expires: 2008-04-26
Abstract
Abstract Disclosed is a method for identifying and isolating gene sequences coding for polypeptide sequences which result in specific functional activities or phenotypes, which may then be synthesized and assembled to form new proteins. The assembled protein may contain only amino acid sequences essential for specific functions, have a new quaternary structure resulting from addition of an amino acid sequence with oligomeric activity, or exhibit multiple activities. Also disclosed is a method for identifying, analyzing and synthesizing amino acid sequences with oligomeric activity which may be used to enhance or add a new activity to a protein. In one embodiment, the piece with oligomeric activity is fused onto a polypeptide with one or more additional activities. In another embodiment, this polypeptide sequence is hybridized with a second polypeptide consisting only of the sequence with oligomeric activity. In a variation of this second method, the first polypeptide may naturally contain a sequence with oligomeric activity and the second polypeptide sequence may be synthesized to complement the naturally occurring sequence. The protein-to-protein interactions serve to stabilize or enhance the activities on the first polypeptide sequences. These methods provide means for enhancing activity in sequences that occur naturally or in sequences which are synthesized from a variety of sources. The coupling piece may be spatially remote from the active or functional domain and still be effective in producing a protein with enhanced or restored or stabilized activity.
Inventors
- 👤 Maria Jasin
- 👤 Paul R. Schimmel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 20:34
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/11; C12N15/52
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
221 words
A method for mapping and cloning nucleotide sequences that encode amino acid sequences having oligomeric or adhesive properties which can be used to impart greater stability to or restore or enhance the intrinsic activity of a protein molecule comprising: (a) cloning in a first plasmid a first nucleotide sequence encoding a first polypeptide, not including regulatory sequences, comprising an amino acid sequence with a first activity joined to an amino acid sequence with oligomeric activity, wherein oligomeric activity is defined as structure resulting in the assembly of a complex between the sequence with oligomeric activity and another polypeptide; (b) cloning in a second plasmid a second nucleotide sequence encoding a second polypeptide, not including regulatory sequences, wherein said second polypeptide comprises a portion of the amino acid sequences of said first polypeptide; (c) expressing said first and second nucleotide sequences cloned in steps (a) and (b) resulting in the synthesis of said first and second polypeptides; (d) permitting said first and second polypeptides synthesized from the nucleotide sequences cloned in steps (a) and (b) to combine; (e) screening the combined polypeptides for assembly of a complex between said first and second-polypeptides; and (f) measuring the activity of the complexed polypeptides of step (d) to determine if the polypeptide of step (b) has increased the activity of the polypeptide of step (a).
Claim 2
Independent Claim
221 words
A method for mapping and cloning nucleotide sequences that encode amino acid sequences having oligomeric or adhesive properties which can be used to impart greater stability to or restore or enhance the intrinsic activity of a protein molecule comprising: (a) cloning in a first plasmid a first nucleotide sequence encoding a first polypeptide, not including regulatory sequences, comprising an amino acid sequence with a first activity joined to an amino acid sequence with oligomeric activity, wherein oligomeric activity is defined as structure resulting in the assembly of a complex between the sequence with oligomeric activity and another polypeptide; (b) cloning in a second plasmid a second nucleotide sequence encoding a second polypeptide, not including regulatory sequences, wherein said second polypeptide comprises a portion of the amino acid sequences of said first polypeptide; (c) expressing said first and second nucleotide sequences cloned in steps (a) and (b) resulting in the synthesis of said first and second polypeptides; (d) permitting said first and second polypeptides synthesized from the nucleotide sequences cloned in steps (a) and (b) to combine; (e) screening the combined polypeptides for assembly of a complex between said first and second-polypeptides; and (f) measuring the activity of the complexed polypeptides of step (d) to determine if the polypeptide of step (b) has increased the activity of the polypeptide of step (a).
Claim 3
Dependent Claim
24 words
The method of claim 1 comprising further constructing said second nucleotide sequence to encode amino acid sequences of said first polypeptide with oligomeric activity.
Claim 4
Dependent Claim
48 words
The method of claim 2 further comprising locating said nucleotide sequence encoding amino acid sequences other than those for said first activity and amino acid sequences with oligomeric activity between said nucleotide sequences encoding said amino acid sequence with said first activity and the carboxyl-terminus of said polypeptide.
Claim 5
Dependent Claim
58 words
The method of claim 1 further comprising selecting said polypeptide having a first activity from the group of polypeptides having a measurable activity in the biosynthesis of cellular constituents, metabolites, nucleotides, amino acids, nucleic acids, cofactors, proteins, lipids, sugars, polysaccharides; polypeptides having a hormonal activity; polypeptides acting in growth regulation; and peptides and proteins regulating the immune response.
Claim 6
Dependent Claim
24 words
The method of claim 1 further comprising constructing a third recombinant plasmid comprising said nucleotide sequence encoding said amino acid sequence with oligomeric activity.
Claim 7
Dependent Claim
24 words
The method of claim 5 further comprising inserting said third plasmid into a host strain and synthesizing an amino acid sequence with oligomeric activity.
Claim 8
Dependent Claim
18 words
The method of claim 6 further comprising producing hybrid proteins comprising said amino acid sequence with oligomeric activity.
Claim 9
Dependent Claim
27 words
The method of claim 7 wherein said hybrid protein has enzymatic activity and is selected for enhanced intrinsic catalytic activity in comparison to the naturally occurring enzyme.
Claim 10
Independent Claim
108 words
A method for producing a gene for a polypeptide with one or more intrinsic activities enhanced or stablized comprising: (a) inserting into a first plasmid a first nucleotide sequence encoding a first polypeptide with a first intrinsic activity, not including regulatory sequences, and (b) inserting into said plasmid a second nucleotide sequence, encoding a second amino acid sequence with oligomeric activity, wherein oligomeric activity is defined as structure resulting in the assembly of a complex between the sequence with oligomeric activity and another polypeptide, as a continuation of and in the same reading frame as the first nucleotide sequence, wherein said oligomeric activity enhances said first intrinsic activity.
Claim 11
Independent Claim
108 words
A method for producing a gene for a polypeptide with one or more intrinsic activities enhanced or stablized comprising: (a) inserting into a first plasmid a first nucleotide sequence encoding a first polypeptide with a first intrinsic activity, not including regulatory sequences, and (b) inserting into said plasmid a second nucleotide sequence, encoding a second amino acid sequence with oligomeric activity, wherein oligomeric activity is defined as structure resulting in the assembly of a complex between the sequence with oligomeric activity and another polypeptide, as a continuation of and in the same reading frame as the first nucleotide sequence, wherein said oligomeric activity enhances said first intrinsic activity.
Claim 12
Dependent Claim
35 words
The method of claim 9 further comprising inserting into said first plasmid additional nucleotide sequences for additional intrinsic activities that are a continuation of and in the same reading frame as said first nucleotide sequence.
Claim 13
Dependent Claim
14 words
The method of claim 9 further comprising selecting said nucleotide sequences from different sources.
Claim 14
Independent Claim
144 words
A method for stablizing or enhancing one or more intrinsic activities in a polypeptide comprising: (a) cloning in a first plasmid a first nucleotide sequence, not including regulatory sequence, encoding a first polypeptide with a first intrinsic activity joined to an amino acid sequence with oligomeric activity, wherein oligomeric activity is defined as structure resulting in the assembly of a complex between the sequence with oligomeric activity and another polypeptide; (b) cloning in a second plasmid a second nucleotide sequence, not including regulatory sequences, encoding a second polypeptide, wherein said second polypeptide comprises said amino acid sequence of step (a) with oligomeric activity; (c) expressing said first and second nucleotide sequences resulting in the synthesis of said first and second polypeptides; (d) permitting the complex formation between said first and second polypeptides which results in enhancing one or more intrinsic activities in a polypeptide.
Claim 15
Independent Claim
144 words
A method for stablizing or enhancing one or more intrinsic activities in a polypeptide comprising: (a) cloning in a first plasmid a first nucleotide sequence, not including regulatory sequence, encoding a first polypeptide with a first intrinsic activity joined to an amino acid sequence with oligomeric activity, wherein oligomeric activity is defined as structure resulting in the assembly of a complex between the sequence with oligomeric activity and another polypeptide; (b) cloning in a second plasmid a second nucleotide sequence, not including regulatory sequences, encoding a second polypeptide, wherein said second polypeptide comprises said amino acid sequence of step (a) with oligomeric activity; (c) expressing said first and second nucleotide sequences resulting in the synthesis of said first and second polypeptides; (d) permitting the complex formation between said first and second polypeptides which results in enhancing one or more intrinsic activities in a polypeptide.
Claim 16
Dependent Claim
35 words
The method of claim 12 wherein said first polypeptide is selected from the group of naturally occurring polypeptides comprising an amino acid sequence for a first activity and an amino acid sequence with oligomeric activity.
Claim 17
Dependent Claim
15 words
The method of claim 12 wherein said first polypeptide is constructed by recombinant DNA techniques.
Claim 18
Dependent Claim
33 words
The method of claim 14 further comprising inserting nucleotide sequences encoding additional activities into said first plasmid that are a continuation of and in the same reading frame as said first nucleotide sequence.
Claim 19
Dependent Claim
35 words
The method of claim 15 further comprising inserting nucleotide sequences encoding additional amino acid sequences into said second plasmid that are a continuation of and in the same reading frame as said second nucleotide sequence.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-08-27 | 1994-02-26 | 1994-08-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-08-27 | 1998-02-26 | 1998-08-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-08-27 | 2002-02-26 | 2002-08-28 | $7700.00 | Window Closed / Lapsed |